REDWOOD SHORES, Calif., July 23, 2019 /PRNewswire/ -- Oracle Health Sciences was positioned as a Leader and the highest scoring vendor in Vision and Capability in the Everest Group PEAK Matrix™ 2019 Assessment of Life Sciences Clinical Trials Products. Everest Group assesses vendors based on their market impact (market adoption, value delivered and portfolio mix) and vision and capabilit

NEW YORK, July 23, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") announced today that the 75th patient has been treated in the pivotal Phase 3 SIERRA trial of Iomab-B, thus achieving 50 percent patient enrollment for the trial.

ST. LOUIS, July 23, 2019 /PRNewswire/ -- Sandberg Phoenix launched SPIN, a collaborative solution with IT experts focused on HIPAA and MACRA/MIPS and O

SOUTH PLAINFIELD, N.J., July 23, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2019 financial results and provide an update on the company's business and outlook on Tuesday, August 6, 2019 at 4:30 p.m. (E

TORONTO and PARK CITY, Utah, July 23, 2019 /PRNewswire/ -- DW Healthcare Partners, a private equity firm focused primarily on making control investments in North American middle market healthcare companies, announced the closing of its fifth fund. The fund was oversubscribed and met its cap of USD $610 mil

VANCOUVER, British Columbia, July 23, 2019 /PRNewswire/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces 10 additional dispensaries as CSPA Group, Inc., the Company's wholly-owned subsidiary, continues to expand the availability of its flagship produc

BOTHELL, Wash., July 23, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction t

SALT LAKE CITY, July 23, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced

BOSTON, July 23, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts was recognized as a "Best Place to Work" for disa

HOUSTON, July 23, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced the European Patent Office has issued the decision to